Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Regulation of process retraction and cell migration by EphA3 is mediated by the adaptor protein Nck1.

Hu T, Shi G, Larose L, Rivera GM, Mayer BJ, Zhou R.

Biochemistry. 2009 Jul 14;48(27):6369-78. doi: 10.1021/bi900831k.

PMID:
19505147
2.

Low frequency mutation of the Ephrin receptor A3 gene in hepatocellular carcinoma.

Bae HJ, Song JH, Noh JH, Kim JK, Jung KH, Eun JW, Xie HJ, Ryu JC, Ahn YM, Kim SY, Lee SH, Yoo NJ, Lee JY, Park WS, Nam SW.

Neoplasma. 2009;56(4):331-4.

PMID:
19469653
3.

Mutations of the EPHA2 receptor tyrosine kinase gene cause autosomal dominant congenital cataract.

Zhang T, Hua R, Xiao W, Burdon KP, Bhattacharya SS, Craig JE, Shang D, Zhao X, Mackey DA, Moore AT, Luo Y, Zhang J, Zhang X.

Hum Mutat. 2009 May;30(5):E603-11. doi: 10.1002/humu.20995.

PMID:
19306328
4.

Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis.

Taddei ML, Parri M, Angelucci A, Onnis B, Bianchini F, Giannoni E, Raugei G, Calorini L, Rucci N, Teti A, Bologna M, Chiarugi P.

Am J Pathol. 2009 Apr;174(4):1492-503. doi: 10.2353/ajpath.2009.080473.

PMID:
19264906
5.

Bidirectional modulation of synaptic functions by Eph/ephrin signaling.

Klein R.

Nat Neurosci. 2009 Jan;12(1):15-20. doi: 10.1038/nn.2231. Review.

PMID:
19029886
6.

The EPHA2 gene is associated with cataracts linked to chromosome 1p.

Shiels A, Bennett TM, Knopf HL, Maraini G, Li A, Jiao X, Hejtmancik JF.

Mol Vis. 2008;14:2042-55.

PMID:
19005574
7.

Somatic mutations affect key pathways in lung adenocarcinoma.

Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan MB, Fulton L, Fulton RS, Zhang Q, Wendl MC, Lawrence MS, Larson DE, Chen K, Dooling DJ, Sabo A, Hawes AC, Shen H, Jhangiani SN, Lewis LR, Hall O, Zhu Y, Mathew T, Ren Y, Yao J, Scherer SE, Clerc K, Metcalf GA, Ng B, Milosavljevic A, Gonzalez-Garay ML, Osborne JR, Meyer R, Shi X, Tang Y, Koboldt DC, Lin L, Abbott R, Miner TL, Pohl C, Fewell G, Haipek C, Schmidt H, Dunford-Shore BH, Kraja A, Crosby SD, Sawyer CS, Vickery T, Sander S, Robinson J, Winckler W, Baldwin J, Chirieac LR, Dutt A, Fennell T, Hanna M, Johnson BE, Onofrio RC, Thomas RK, Tonon G, Weir BA, Zhao X, Ziaugra L, Zody MC, Giordano T, Orringer MB, Roth JA, Spitz MR, Wistuba II, Ozenberger B, Good PJ, Chang AC, Beer DG, Watson MA, Ladanyi M, Broderick S, Yoshizawa A, Travis WD, Pao W, Province MA, Weinstock GM, Varmus HE, Gabriel SB, Lander ES, Gibbs RA, Meyerson M, Wilson RK.

Nature. 2008 Oct 23;455(7216):1069-75. doi: 10.1038/nature07423.

PMID:
18948947
8.

Loss of ephrin-A5 function disrupts lens fiber cell packing and leads to cataract.

Cooper MA, Son AI, Komlos D, Sun Y, Kleiman NJ, Zhou R.

Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16620-5. doi: 10.1073/pnas.0808987105.

PMID:
18948590
9.

A subset of signal transduction pathways is required for hippocampal growth cone collapse induced by ephrin-A5.

Yue X, Dreyfus C, Kong TA, Zhou R.

Dev Neurobiol. 2008 Sep 1;68(10):1269-86. doi: 10.1002/dneu.20657.

PMID:
18563700
10.

Autoregulation by the juxtamembrane region of the human ephrin receptor tyrosine kinase A3 (EphA3).

Davis TL, Walker JR, Loppnau P, Butler-Cole C, Allali-Hassani A, Dhe-Paganon S.

Structure. 2008 Jun;16(6):873-84. doi: 10.1016/j.str.2008.03.008.

PMID:
18547520
11.

Eph-ephrin bidirectional signaling in physiology and disease.

Pasquale EB.

Cell. 2008 Apr 4;133(1):38-52. doi: 10.1016/j.cell.2008.03.011. Review.

PMID:
18394988
12.

Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase.

Fang WB, Brantley-Sieders DM, Hwang Y, Ham AJ, Chen J.

J Biol Chem. 2008 Jun 6;283(23):16017-26. doi: 10.1074/jbc.M709934200.

PMID:
18387945
13.

Regulation of angiogenesis by Eph-ephrin interactions.

Kuijper S, Turner CJ, Adams RH.

Trends Cardiovasc Med. 2007 Jul;17(5):145-51. Review.

PMID:
17574121
14.

Multiple effects of ephrin-A5 on cortical neurons are mediated by SRC family kinases.

Zimmer G, Kästner B, Weth F, Bolz J.

J Neurosci. 2007 May 23;27(21):5643-53.

PMID:
17522309
15.

EphrinA1 activates a Src/focal adhesion kinase-mediated motility response leading to rho-dependent actino/myosin contractility.

Parri M, Buricchi F, Giannoni E, Grimaldi G, Mello T, Raugei G, Ramponi G, Chiarugi P.

J Biol Chem. 2007 Jul 6;282(27):19619-28.

PMID:
17449913
16.

Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma.

Balakrishnan A, Bleeker FE, Lamba S, Rodolfo M, Daniotti M, Scarpa A, van Tilborg AA, Leenstra S, Zanon C, Bardelli A.

Cancer Res. 2007 Apr 15;67(8):3545-50.

PMID:
17440062
17.

Bidirectional Eph-ephrin signaling during axon guidance.

Egea J, Klein R.

Trends Cell Biol. 2007 May;17(5):230-8. Review.

PMID:
17420126
18.

Putative dual role of ephrin-Eph receptor interactions in inflammation.

Ivanov AI, Romanovsky AA.

IUBMB Life. 2006 Jul;58(7):389-94. Review.

PMID:
16801213
19.

Sema4D/plexin-B1 activates GSK-3beta through R-Ras GAP activity, inducing growth cone collapse.

Ito Y, Oinuma I, Katoh H, Kaibuchi K, Negishi M.

EMBO Rep. 2006 Jul;7(7):704-9.

PMID:
16799460
20.

Roles of Eph receptors and ephrins in the normal and damaged adult CNS.

Goldshmit Y, McLenachan S, Turnley A.

Brain Res Rev. 2006 Sep;52(2):327-45. Review.

PMID:
16774788
Items per page

Supplemental Content

Support Center